Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [913]
News [2612]
Articles [111]
Editorials [3]
Conferences [85]
elearning [27]
WCLC 2024: PanCan nodule management protocol more effective than LungRADSv1.1 method
WCLC 2024: PanCan nodule management protocol more effective than LungRADSv1.1 method
WCLC 2024: Perioperative nivolumab may provide meaningful improvement in event-free survival compared to only neoadjuvant nivolumab plus chemotherapy for resectable NSCLC
WCLC 2024: Perioperative nivolumab may provide meaningful improvement in event-free survival compared to only...
WCLC 2024: NeoCOAST-2 Data shows combination of Durvalumab with novel agents increases pathological responses in resectable NSCLC -- Data builds on AEGEAN study research
WCLC 2024: NeoCOAST-2 Data shows combination of Durvalumab with novel agents increases pathological responses in...
TGF-beta and RAS signaling are both required for lung cancer metastasis, study finds
TGF-beta and RAS signaling are both required for lung cancer metastasis, study finds
Gut bacteria influence responses to immunotherapy in patients with asbestos related cancer, Leicester study finds
Gut bacteria influence responses to immunotherapy in patients with asbestos related cancer, Leicester study finds
Pancreatic cancers change identity as they transform into aggressive types ― an organoid study
Pancreatic cancers change identity as they transform into aggressive types ― an organoid study
Long-term conditions could delay lung cancer diagnosis, new study finds
Long-term conditions could delay lung cancer diagnosis, new study finds
Scientists discover how the body's killer cells attack cancer
Scientists discover how the body's killer cells attack cancer
Researchers use AI tools to uncover connections between radiotherapy for lung cancer and heart complications
Researchers use AI tools to uncover connections between radiotherapy for lung cancer and heart complications
FDA approves lazertinib with amivantamab-vmjw for non-small lung cancer
FDA approves lazertinib with amivantamab-vmjw for non-small lung cancer

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation